iBody is a biotechnology company with a highly effective platform for monoclonal antibody discovery.

Our proprietary technology combines single-cell and cell-free antibody expression technologies, enabling rapid and comprehensive screening of valuable antibodies from both human and animal sources without missing rare or unique clones.

This innovation allows us to identify high-performance antibodies that were difficult to obtain using conventional methods, even from human samples or immunized animals.

For the discovery of high-quality antibodies essential for pharmaceutical and diagnostic development, iBody is your trusted partner.